cytidine diphosphate choline has been researched along with Disease Exacerbation in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Ancona, C; Calcatelli, E; Cirafici, P; Coco, G; Iester, M; Manni, G; Ottobelli, L; Rossetti, L; Tranchina, L | 1 |
| Secades, JJ | 1 |
| Allevena, F; Centofanti, M; Iester, M; Manni, GL; Ottobelli, L; Rossetti, L | 1 |
| Centofanti, M; Manni, G; Parisi, V; Roberti, G; Sampalmieri, M; Tanga, L | 1 |
| Fedorova, YB; Gavrilova, SI; Kochkina, EG; Kozlova, DI; Nalivaeva, NN; Zhuravin, IА | 1 |
| Castagna, A; Conforti, R; Cotroneo, AM; Gareri, P; Marino, S; Putignano, D; Putignano, S; Santamaria, F | 1 |
| Brickman, AM; Browndyke, J; Cohen, RA; Gordon, N; Gunstad, J; Haque, O; Moser, DJ; Ott, BR; Paul, RH | 1 |
| De Gregorio, F; Liguori, A; Pecori-Giraldi, J; Virno, M | 1 |
1 review(s) available for cytidine diphosphate choline and Disease Exacerbation
| Article | Year |
|---|---|
Citicoline: pharmacological and clinical review, 2016 update.
Topics: Brain Injuries, Traumatic; Cognitive Dysfunction; Cytidine Diphosphate Choline; Disease Progression; Humans; Nootropic Agents; Stroke | 2016 |
3 trial(s) available for cytidine diphosphate choline and Disease Exacerbation
| Article | Year |
|---|---|
Can Treatment With Citicoline Eyedrops Reduce Progression in Glaucoma? The Results of a Randomized Placebo-controlled Clinical Trial.
Topics: Administration, Ophthalmic; Aged; Aged, 80 and over; Cytidine Diphosphate Choline; Disease Progression; Double-Blind Method; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Middle Aged; Nerve Fibers; Nootropic Agents; Ophthalmic Solutions; Retinal Ganglion Cells; Tonometry, Ocular; Visual Fields | 2020 |
Citicoline oral solution in glaucoma: is there a role in slowing disease progression?
Topics: Administration, Oral; Aged; Cytidine Diphosphate Choline; Disease Progression; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Nootropic Agents; Prospective Studies; Treatment Outcome; Visual Fields | 2013 |
Progressive morphometric and cognitive changes in vascular dementia.
Topics: Aged; Aged, 80 and over; Anthropometry; Brain; Cerebral Infarction; Cytidine Diphosphate Choline; Dementia, Vascular; Disease Progression; Female; Humans; Magnetic Resonance Imaging; Male; Nootropic Agents; Severity of Illness Index | 2005 |
4 other study(ies) available for cytidine diphosphate choline and Disease Exacerbation
| Article | Year |
|---|---|
A preliminary study of the neuroprotective role of citicoline eye drops in glaucomatous optic neuropathy.
Topics: Animals; Cytidine Diphosphate Choline; Disease Models, Animal; Disease Progression; Dose-Response Relationship, Drug; Electroretinography; Glaucoma, Open-Angle; Mice; Nootropic Agents; Ophthalmic Solutions; Optic Nerve Diseases; Retinal Ganglion Cells | 2014 |
[The activity of blood serum cholinesterases and neprilysin as potential biomarkers of mild-cognitive impairment and Alzheimer's disease].
Topics: Acetylcholinesterase; Aged; Alzheimer Disease; Biomarkers; Butyrylcholinesterase; Cognitive Dysfunction; Cytidine Diphosphate Choline; Disease Progression; Female; Humans; Male; Neprilysin; Nootropic Agents | 2015 |
The Citicholinage Study: Citicoline Plus Cholinesterase Inhibitors in Aged Patients Affected with Alzheimer's Disease Study.
Topics: Administration, Oral; Affect; Aged; Aged, 80 and over; Alzheimer Disease; Case-Control Studies; Cholinesterase Inhibitors; Cognition; Comorbidity; Cytidine Diphosphate Choline; Disease Progression; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Mental Status and Dementia Tests; Nootropic Agents; Retrospective Studies; Treatment Outcome | 2017 |
The protective effect of citicoline on the progression of the perimetric defects in glaucomatous patients (perimetric study with a 10-year follow-up).
Topics: Cytidine Diphosphate Choline; Disease Progression; Follow-Up Studies; Glaucoma; Humans; Injections, Intramuscular; Nootropic Agents; Prospective Studies; Retina; Visual Field Tests; Visual Fields | 2000 |